The Breast Cancer Susceptibility Gene BRCA1 Is Required for Subnuclear Assembly of Rad51 and Survival following Treatment with the DNA Cross-linking Agent Cisplatin
Top Cited Papers
Open Access
- 1 August 2000
- journal article
- research article
- Published by Elsevier in Journal of Biological Chemistry
- Vol. 275 (31) , 23899-23903
- https://doi.org/10.1074/jbc.c000276200
Abstract
No abstract availableKeywords
This publication has 60 references indexed in Scilit:
- BRCA1 deficient embryonic stem cells display a decreased homologous recombination frequency and an increased frequency of non-homologous recombination that is corrected by expression of a Brca1 transgeneOncogene, 1999
- Association of BRCA1 with the hRad50-hMre11-p95 Complex and the DNA Damage ResponseScience, 1999
- Centrosome Amplification and a Defective G2–M Cell Cycle Checkpoint Induce Genetic Instability in BRCA1 Exon 11 Isoform–Deficient CellsMolecular Cell, 1999
- HMG1 protein inhibits the translesion synthesis of the major DNA cisplatin adduct by cell extracts 1 1Edited by M. YanivJournal of Molecular Biology, 1997
- Transcriptional activation functions in BRCA2Nature, 1997
- The complete BRCA2 gene and mutations in chromosome 13q-linked kindredsNature Genetics, 1996
- Identification of the breast cancer susceptibility gene BRCA2Nature, 1995
- Cyclophosphamide: Review of its mutagenicity for an assessment of potential germ cell risksMutation Research - Fundamental and Molecular Mechanisms of Mutagenesis, 1995
- Effects of cis-platinum(II) diamminedichloride on survival and the rate of DNA synthesis in synchronously growing Chinese hamster V79-379A cells in the absence and presence of caffeine inhibited post-replication repair; Evidence for an inducible repair mechanismChemico-Biological Interactions, 1978
- Removal of psoralen interstrand cross-links from DNA of Escherichia coli: Mechanism and genetic controlJournal of Molecular Biology, 1976